$WORX
SCWorx Corp. Stock $worx

$worx Overview Financials Valuation SEC Filings Company Website

2023 Q3 Form 10-Q Financial Statement

#000121390023066853 Filed on August 14, 2023

Income Statement

Concept	2023 Q3	2023 Q2	2022 Q4
Revenue	$906.1K	$991.1K	$1.028M
YoY Change	-8.19%	-0.13%	-17.79%
Cost Of Revenue	$666.8K	$616.0K	$610.0K
YoY Change	-3.83%	-1.21%	-3.15%
Gross Profit	$239.3K	$375.1K	$417.9K
YoY Change	-18.5%	1.68%	-32.65%
Gross Profit Margin	26.41%	37.84%	40.65%
Selling, General & Admin	$1.100M	$523.5K	$675.8K
YoY Change	32.1%	-43.84%	-54.33%
% of Gross Profit	459.69%	139.58%	161.74%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization			$0.00
YoY Change			-100.0%
% of Gross Profit			0.0%
Operating Expenses	$1.090M	$523.5K	$675.8K
YoY Change	-28.57%	-66.35%	-54.33%
Operating Profit	-$858.0K	-$148.5K	-$258.0K
YoY Change	59.15%	-73.65%	-69.97%
Interest Expense	$0.00	$5.459K
YoY Change		-83.34%
% of Operating Profit
Other Income/Expense, Net	-$276.00	-$5.459K
YoY Change	-100.2%
Pretax Income	-$858.3K	-$153.9K	-$258.0K
YoY Change	114.82%	-72.68%	-69.97%
Income Tax			$0.00
% Of Pretax Income
Net Earnings	-$858.3K	-$153.9K	-$258.0K
YoY Change	114.82%	-72.68%	-69.97%
Net Earnings / Revenue	-94.72%	-15.53%	-25.1%
Basic Earnings Per Share	-$0.05	-$0.01
Diluted Earnings Per Share	-$0.05	-$0.01	-$0.02
COMMON SHARES
Basic Shares Outstanding	16.70M shares	13.02M shares	13.01M shares
Diluted Shares Outstanding	16.90M shares	13.82M shares

Balance Sheet

Concept	2023 Q3	2023 Q2	2022 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$70.00K	$133.0K	$249.5K
YoY Change	-80.65%	466.33%	250.96%
Cash & Equivalents	$72.43K	$133.0K	$249.5K
Short-Term Investments
Other Short-Term Assets	$60.00K	$90.53K	$295.2K
YoY Change	-81.43%	-72.39%	361.65%
Inventory
Prepaid Expenses
Receivables	$322.7K	$458.8K	$336.0K
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$450.1K	$682.4K	$880.7K
YoY Change	-50.89%	-2.31%	16.42%
LONG-TERM ASSETS
Property, Plant & Equipment		$0.00	$0.00
YoY Change
Goodwill	$8.366M	$8.366M	$8.366M
YoY Change	0.0%	0.0%	0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets	$8.366M	$8.366M	$8.366M
YoY Change	0.0%	0.0%	0.0%
TOTAL ASSETS
Total Short-Term Assets	$450.1K	$682.4K	$880.7K
Total Long-Term Assets	$8.366M	$8.366M	$8.366M
Total Assets	$8.817M	$9.049M	$9.247M
YoY Change	-5.03%	-0.18%	1.36%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$23.47K		$600.0K
YoY Change	-96.09%		0.0%
Accrued Expenses		$1.391M	$1.364M
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$2.557M	$2.340M	$2.323M
YoY Change	9.77%	-10.86%	1.69%
LONG-TERM LIABILITIES
Long-Term Debt	$100.0K	$114.3K	$147.8K
YoY Change	-35.22%	-61.12%	-65.92%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$99.90K	$114.3K	$147.7K
YoY Change	-35.29%	-61.12%	-65.92%
TOTAL LIABILITIES
Total Short-Term Liabilities	$2.557M	$2.340M	$2.323M
Total Long-Term Liabilities	$99.90K	$114.3K	$147.7K
Total Liabilities	$2.657M	$2.455M	$2.471M
YoY Change	6.97%	-15.92%	-9.1%
SHAREHOLDERS EQUITY
Retained Earnings	-$27.27M	-$26.41M	-$25.86M
YoY Change	6.52%	4.81%	7.69%
Common Stock	$17.91K	$16.16K	$13.01K
YoY Change	37.66%	37.8%	15.21%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$6.160M	$6.594M	$6.777M
YoY Change
Total Liabilities & Shareholders Equity	$8.817M	$9.049M	$9.247M
YoY Change	-5.03%	-0.18%	1.36%

Cashflow Statement

Concept	2023 Q3	2023 Q2	2022 Q4
OPERATING ACTIVITIES
Net Income	-$858.3K	-$153.9K	-$258.0K
YoY Change	114.82%	-72.68%	-69.97%
Depreciation, Depletion And Amortization			$0.00
YoY Change			-100.0%
Cash From Operating Activities	-$370.0K	-$347.8K	-$112.3K
YoY Change	-4.35%	-2388.36%	-66.04%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities	$0.00	$0.00	$0.00
YoY Change
Cash From Investing Activities	$0.00	$0.00	$0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	310.0K	231.1K	0.000
YoY Change	-57.24%
NET CHANGE
Cash From Operating Activities	-370.0K	-347.8K	-112.3K
Cash From Investing Activities	0.000	0.000	0.000
Cash From Financing Activities	310.0K	231.1K	0.000
Net Change In Cash	-60.00K	-116.7K	-112.3K
YoY Change	-117.74%	-867.7%	-66.04%
FREE CASH FLOW
Cash From Operating Activities	-$370.0K	-$347.8K	-$112.3K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	us-gaap	Income Taxes Paid IncomeTaxesPaid		usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross		usd
CY2023Q2	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross		usd
	dei	Local Phone Number LocalPhoneNumber	472-9679
	dei	Security12b Title Security12bTitle	Common stock, $0.001 par value per share
	dei	Trading Symbol TradingSymbol	WORX
	dei	Security Exchange Name SecurityExchangeName	NASDAQ
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
	dei	Entity Shell Company EntityShellCompany	false
CY2023Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	16696766	shares
CY2023Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	133034	usd
	us-gaap	Gain Loss On Sales Of Consumer Loans GainLossOnSalesOfConsumerLoans		usd
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2023-06-30
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-37899
	dei	Entity Registrant Name EntityRegistrantName	SCWORX CORP.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	47-5412331
	dei	Entity Address Address Line1 EntityAddressAddressLine1	590 Madison Avenue
	dei	Entity Address Address Line2 EntityAddressAddressLine2	21st Floor
	dei	Entity Address City Or Town EntityAddressCityOrTown	New York
	dei	Entity Address State Or Province EntityAddressStateOrProvince	NY
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	10022
	dei	City Area Code CityAreaCode	(844)
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	249462	usd
CY2023Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	458798	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	336033	usd
CY2023Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	90533	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	295180	usd
CY2023Q2	us-gaap	Assets Current AssetsCurrent	682365	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	880675	usd
CY2023Q2	us-gaap	Goodwill Goodwill	8366467	usd
CY2022Q4	us-gaap	Goodwill Goodwill	8366467	usd
CY2023Q2	us-gaap	Assets Assets	9048832	usd
CY2022Q4	us-gaap	Assets Assets	9247142	usd
CY2023Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1391494	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1364202	usd
CY2023Q2	worx	Accounts Payables And Accrued Liabilities Related Party AccountsPayablesAndAccruedLiabilitiesRelatedParty	153838	usd
CY2022Q4	worx	Accounts Payables And Accrued Liabilities Related Party AccountsPayablesAndAccruedLiabilitiesRelatedParty	153838	usd
CY2023Q2	worx	Shareholder Advance ShareholderAdvance	83811	usd
CY2022Q4	worx	Shareholder Advance ShareholderAdvance	100000	usd
CY2023Q2	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	586083	usd
CY2022Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	579833	usd
CY2023Q2	worx	Equity Financing Current EquityFinancingCurrent	125000	usd
CY2022Q4	worx	Equity Financing Current EquityFinancingCurrent	125000	usd
CY2023Q2	us-gaap	Liabilities Current LiabilitiesCurrent	2340226	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	2322873	usd
CY2023Q2	us-gaap	Long Term Loans Payable LongTermLoansPayable	114298	usd
CY2022Q4	us-gaap	Long Term Loans Payable LongTermLoansPayable	147749	usd
CY2023Q2	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	114298	usd
CY2022Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	147749	usd
CY2023Q2	us-gaap	Liabilities Liabilities	2454524	usd
CY2022Q4	us-gaap	Liabilities Liabilities	2470622	usd
CY2023Q2	us-gaap	Preferred Stock Value PreferredStockValue	40	usd
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue	40	usd
CY2023Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	45000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	45000000	shares
CY2023Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	16159878	shares
CY2023Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	16159878	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	13010409	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	13010409	shares
CY2023Q2	us-gaap	Common Stock Value CommonStockValue	16160	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	13011	usd
CY2023Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	32990617	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	32022166	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	600000	usd
CY2023Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-26412509	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-25858697	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	6594308	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	6776520	usd
CY2023Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	9048832	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	9247142	usd
CY2023Q2	us-gaap	Revenues Revenues	991099	usd
CY2022Q2	us-gaap	Revenues Revenues	992424	usd
	us-gaap	Revenues Revenues	1988548	usd
	us-gaap	Revenues Revenues	2023373	usd
CY2023Q2	us-gaap	Cost Of Revenue CostOfRevenue	616030	usd
CY2022Q2	us-gaap	Cost Of Revenue CostOfRevenue	623548	usd
	us-gaap	Cost Of Revenue CostOfRevenue	1305492	usd
	us-gaap	Cost Of Revenue CostOfRevenue	1321184	usd
CY2023Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	523532	usd
CY2022Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	932239	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1230936	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2031693	usd
CY2023Q2	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	1139562	usd
CY2022Q2	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	1555787	usd
	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	2536428	usd
	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	3352877	usd
CY2023Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-148463	usd
CY2022Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-563363	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-547880	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-1329504	usd
CY2023Q2	us-gaap	Interest Expense InterestExpense	5459	usd
	us-gaap	Interest Expense InterestExpense	5932	usd
	us-gaap	Gain Loss On Sales Of Consumer Loans GainLossOnSalesOfConsumerLoans	139595	usd
CY2023Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-5459	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-5932	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	139595	usd
CY2023Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-153922	usd
CY2022Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-563363	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-553812	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1189909	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-153922	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-563363	usd
	us-gaap	Net Income Loss NetIncomeLoss	-553812	usd
	us-gaap	Net Income Loss NetIncomeLoss	-1189909	usd
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.01
CY2022Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.05
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.04
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.1
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	13817517	shares
CY2022Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	11438071	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	13420527	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	11386773	shares
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	6524503	usd
CY2023Q2	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	44167	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	31687	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Share Based Compensation Gross StockIssuedDuringPeriodValueShareBasedCompensationGross	147873	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-153922	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	6594308	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	6776520	usd
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	44167	usd
	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	31687	usd
	us-gaap	Stock Issued During Period Value Share Based Compensation Gross StockIssuedDuringPeriodValueShareBasedCompensationGross	295746	usd
	us-gaap	Net Income Loss NetIncomeLoss	-553812	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	6594308	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	6211092	usd
CY2022Q2	worx	Commitment Shares Issued In Conjunction With Capital Raise1 CommitmentSharesIssuedInConjunctionWithCapitalRaise1	200000	usd
CY2022Q2	us-gaap	Stock Issued During Period Value Share Based Compensation Gross StockIssuedDuringPeriodValueShareBasedCompensationGross	297981	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-563363	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	6145710	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	6405070	usd
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	85000	usd
	worx	Commitment Shares Issued In Conjunction With Capital Raise1 CommitmentSharesIssuedInConjunctionWithCapitalRaise1	200000	usd
	us-gaap	Stock Issued During Period Value Share Based Compensation Gross StockIssuedDuringPeriodValueShareBasedCompensationGross	645549	usd
	us-gaap	Net Income Loss NetIncomeLoss	-1189909	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	6145710	usd
	us-gaap	Net Income Loss NetIncomeLoss	-553812	usd
	us-gaap	Net Income Loss NetIncomeLoss	-1189909	usd
	worx	Gain Loss On Settlement Of Accounts Payable GainLossOnSettlementOfAccountsPayable	139595	usd
	worx	Change In Inventory Value ChangeInInventoryValue	112100	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	295746	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	645549	usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	78125	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	122765	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-84135	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	25353	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	63961	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	71459	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	309722	usd
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	6250	usd
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	116250	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-328475	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-47584	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	261687	usd
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	33451	usd
	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	-16189	usd
	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	160085	usd
	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	160085	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	212047	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-116428	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-47584	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	249462	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	71075	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	133034	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	23491	usd
	us-gaap	Interest Paid Net InterestPaidNet	5932	usd
	worx	Commitment Shares Issued In Conjunction With Capital Raise Amount CommitmentSharesIssuedInConjunctionWithCapitalRaiseAmount	200000	usd
	worx	Shares Issued For Vested Restricted Stock Units SharesIssuedForVestedRestrictedStockUnits	228	usd
	worx	Shares Issued For Vested Restricted Stock Units SharesIssuedForVestedRestrictedStockUnits	72	usd
	worx	Shares Issued For Equity Financings SharesIssuedForEquityFinancings	1941	usd
	us-gaap	Stock Issued1 StockIssued1	229	usd
CY2023Q2	worx	Acquired Technology Predecessor Cost AcquiredTechnologyPredecessorCost	0	usd
CY2023Q2	us-gaap	Cash Uninsured Amount CashUninsuredAmount	250000	usd
	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Concentration of Credit and Other Risks</i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Financial instruments that potentially subject the Company to significant concentrations of credit risk consist principally of cash, accounts receivable and warrants. The Company believes that any concentration of credit risk in its accounts receivable is substantially mitigated by the Company’s evaluation process, relatively short collection terms and the high level of credit worthiness of its customers. The Company performs ongoing internal credit evaluations of its customers’ financial condition, obtains deposits and limits the amount of credit extended when deemed necessary but generally requires no collateral.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Significant customers are those which represent more than 10% of the Company’s revenue for each period presented, or the Company’s accounts receivable balance as of each respective balance sheet date. For each significant customer, revenue as a percentage of total revenue and accounts receivable as a percentage of total net accounts receivable are as follows:</p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center">Revenue</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="6" style="text-align: center"> </td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center">For the six months ended</td><td style="padding-bottom: 1.5pt"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center">Accounts Receivable</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">June 30,</td><td style="padding-bottom: 1.5pt"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">June 30,</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold; border-bottom: Black 1.5pt solid">Customers</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 52%; text-align: left">Customer A</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">11</td><td style="width: 1%; text-align: left">%</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">13</td><td style="width: 1%; text-align: left">%</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">13</td><td style="width: 1%; text-align: left">%</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">13</td><td style="width: 1%; text-align: left">%</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Customer B</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">10</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">10</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">44</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">11</td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Customer C</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">15</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">12</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">8</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">18</td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Customer D</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">11</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">12</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">4</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">6</td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Customer E</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">14</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Customer F</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">0</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">0</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">19</td><td style="text-align: left">%</td></tr> </table>
CY2023Q2	us-gaap	Revenue Remaining Performance Obligation Percentage RevenueRemainingPerformanceObligationPercentage	0.10	pure
CY2023Q2	worx	Gowns In Inventory GownsInInventory	87000	usd
CY2021Q4	us-gaap	Other Inventory OtherInventory	366840	usd
CY2023Q2	us-gaap	Inventory Gross InventoryGross	523440	usd
CY2022Q4	us-gaap	Inventory Gross InventoryGross	523440	usd
CY2023Q2	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	523440	usd
CY2022Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	523440	usd
CY2020Q2	us-gaap	Long Term Debt Percentage Bearing Fixed Interest Rate LongTermDebtPercentageBearingFixedInterestRate	0.60	pure
CY2020Q2	us-gaap	Debt Instrument Interest Rate Stated Percentage DebtInstrumentInterestRateStatedPercentage	0.01	pure
CY2020Q2	us-gaap	Debt Instrument Term DebtInstrumentTerm	P2Y
CY2022Q2	us-gaap	Debt Instrument Maturity Date DebtInstrumentMaturityDate	2025-03-05
	us-gaap	Line Of Credit Facility Average Outstanding Amount LineOfCreditFacilityAverageOutstandingAmount	139569	usd
	us-gaap	Deferred Revenue Additions DeferredRevenueAdditions	586083	usd
CY2022	us-gaap	Deferred Revenue Additions DeferredRevenueAdditions	579833	usd
CY2023Q2	worx	Contract Liabilities ContractLiabilities	586083	usd
CY2022Q4	worx	Contract Liabilities ContractLiabilities	579833	usd
CY2023Q2	worx	Stock Issued During Period Value Stock Options Exercised Net Of Tax Benefits Expense StockIssuedDuringPeriodValueStockOptionsExercisedNetOfTaxBenefitsExpense	228568	shares
	us-gaap	Use Of Estimates UseOfEstimates	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Use of Estimates</i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported and disclosed in the consolidated financial statements and accompanying notes. The Company regularly evaluates estimates and assumptions related to the allowance for doubtful accounts, the estimated useful lives and recoverability of long-lived assets, stock-based compensation, goodwill, and deferred income tax asset valuation allowances. The Company bases its estimates and assumptions on current facts, historical experience and various other factors that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the accrual of costs and expenses that are not readily apparent from other sources. The actual results experienced by the Company may differ materially and adversely from the Company’s estimates. To the extent there are material differences between the estimates and the actual results, future results of operations will be affected. Actual results could differ materially from those estimates.</p>
CY2023Q2	us-gaap	Operating Lease Cost OperatingLeaseCost	435	usd
CY2022Q2	us-gaap	Operating Lease Cost OperatingLeaseCost	434	usd
	us-gaap	Operating Lease Cost OperatingLeaseCost	870	usd
	us-gaap	Operating Lease Cost OperatingLeaseCost	921	usd
CY2023Q2	us-gaap	Lease Cost LeaseCost	435	usd
CY2022Q2	us-gaap	Lease Cost LeaseCost	434	usd
	us-gaap	Lease Cost LeaseCost	870	usd
	us-gaap	Lease Cost LeaseCost	921	usd
	us-gaap	Loss Contingency Actions Taken By Plaintiff LossContingencyActionsTakenByPlaintiff	Under the terms of this agreement, (i) the insurers for the Company and Marc Schessel (former CEO) agreed to a cash payment to the class plaintiffs (ii) the former CEO agreed to transfer 100,000 shares of company common stock to the class plaintiffs, and (iii) the Company agreed to issue $600,000 worth of common stock to the class plaintiffs, in exchange for which all parties were released from all claims related to the securities class action litigation. After giving effect to the share issuance by the Company, the Company believes that it has satisfied the accrued retention liability of $700,000.
CY2022Q2	us-gaap	Loss Contingency Damages Sought Value LossContingencyDamagesSoughtValue	190000	usd
CY2022Q4	us-gaap	Loss Contingency Accrual Carrying Value Period Increase Decrease LossContingencyAccrualCarryingValuePeriodIncreaseDecrease	257545.63	usd
	us-gaap	Loss Contingency Damages Sought Value LossContingencyDamagesSoughtValue	500000	usd
CY2023Q2	us-gaap	Legal Fees LegalFees	69163.98	usd
CY2022Q2	us-gaap	Loss Contingency Settlement Agreement Terms LossContingencySettlementAgreementTerms	on or about April 6, 2022, the Company reached a settlement in principle with the SEC Staff which, subject to a few changes, was subsequently approved by the Commission in which the Company agreed to resolve the SEC’s investigation regarding the April 13, 2020 press release and related disclosures (related to Covid-19 rapid test kits) through the Company’s payment of (a) a civil monetary penalty of $125,000, payable in 4 equal installments over 12 months and (b) disgorgement of $471,000 and prejudgment interest in the amount of $32,761.56 which payment is to be deemed satisfied by the Company’s issuance, no later than 30 days after the entry of the Class Distribution Order in the class action entitled Yannes v. SCWorx Corp. of shares of the Company’s common stock, valued at $600,000 at the time of issuance to authorized claimants in the Yannes settlement, provided that the Class Distribution Order is entered within 365 days from the entry of the Final Judgment in the SEC action. On May 31, 2022, the Commission filed a complaint against Marc Schessel and the Company in the United States District Court for the District of New Jersey alleging violations of Sections 17(a)(1), 17(a)(2), and 17(a)(3) of the Securities Act of 1933 (the “Securities Act”), Section 10(b) of the Securities Exchange Act of 1934 (the “Exchange Act”), and Rules 10b-5(a), 10b-5(b), and 10b-5(c) thereunder relating to the April 13, 2020 press release and related disclosures we made in relation to the transaction involving COVID-19 test kits. At the same time, on May 31, 2022, the Commission filed a motion for approval of the Consent Judgment which contained the aforementioned fine, disgorgement requirement as well as an agreement by the Company to an injunction permanently restraining and enjoining the Company from violating Section 10(b) of the Securities Exchange Act of 1934 (“Exchange Act”) [15 U.S.C. § 78j(b)] and Rules 10b-5(a), (b), and (c) thereunder [17 C.F.R § 240.10b .. 5(a), (b), (c)]; and Section 17(a) of the Securities Act of 1933 (“Securities Act’’) [15 U.S.C. § 77q(a)].On June 2, 2022, the Court granted the motion, approved the settlement and entered a final judgment. SCWorx has paid all installments on the monetary penalty of $125,000 and has issued Company common stock valued at $600,000 to the authorized claimants in the Yannes settlement in full satisfaction of its financial obligations under the Consent Judgement.
CY2022Q2	us-gaap	Litigation Settlement Amount Awarded To Other Party LitigationSettlementAmountAwardedToOtherParty	125000	usd
CY2023Q1	worx	Share Based Compensation Arrangement By Share Based Payment Award Options Vested Restricted Units ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedRestrictedUnits	11332	shares
CY2023Q2	worx	Share Based Compensation Arrangement By Share Based Payment Award Options Vested Restricted Units ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedRestrictedUnits	216667	shares
CY2023Q2	worx	Shares Issued As Settlements Of Accounts Payable1 SharesIssuedAsSettlementsOfAccountsPayable1	102096	shares
CY2023Q2	worx	Accounts Payable Current1 AccountsPayableCurrent1	26545	usd
CY2023Q2	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	0.26
CY2023Q2	worx	Shares Issued As Settlements Of Accounts Payable1 SharesIssuedAsSettlementsOfAccountsPayable1	48948	shares
CY2023Q2	worx	Accounts Payable Current1 AccountsPayableCurrent1	17621	usd
CY2023Q2	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	0.36
CY2023Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	300000	shares
CY2023Q2	worx	Aggregate Net Proceeds AggregateNetProceeds	127053	usd
CY2023Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	300000	shares
CY2023Q2	worx	Aggregate Net Proceeds AggregateNetProceeds	134634	usd
CY2023Q2	us-gaap	Class Of Warrant Or Right Unissued ClassOfWarrantOrRightUnissued	823078	shares
CY2023Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.65
CY2020Q2	worx	Received Amount ReceivedAmount	515000	usd
CY2020Q2	us-gaap	Financing Receivable Sale FinancingReceivableSale	565000	usd
CY2020Q2	us-gaap	Common Stock Dividends Shares CommonStockDividendsShares	135527	shares
CY2020Q2	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	3.8
CY2020Q2	us-gaap	Class Of Warrant Or Right Unissued ClassOfWarrantOrRightUnissued	169409	shares
CY2020Q2	us-gaap	Warrant Exercise Price Increase WarrantExercisePriceIncrease	4
CY2023Q2	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	415000	usd
CY2023Q2	worx	Equity Financing Current EquityFinancingCurrent	125000	usd
	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Expense UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense	148240	usd
CY2022	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Expense UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense	222000	usd
CY2023Q2	us-gaap	Share Based Compensation ShareBasedCompensation	147873	usd
CY2022Q2	us-gaap	Share Based Compensation ShareBasedCompensation	297981	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	295746	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	645549	usd
CY2023Q2	worx	Share Based Compensation Common Stock ShareBasedCompensationCommonStock	147873	usd
CY2022Q2	worx	Share Based Compensation Common Stock ShareBasedCompensationCommonStock	297981	usd
	worx	Share Based Compensation Common Stock ShareBasedCompensationCommonStock	295746	usd
	worx	Share Based Compensation Common Stock ShareBasedCompensationCommonStock	645549	usd
CY2023Q2	worx	Share Based Compensation Total ShareBasedCompensationTotal	147873	usd
CY2022Q2	worx	Share Based Compensation Total ShareBasedCompensationTotal	297981	usd
	worx	Share Based Compensation Total ShareBasedCompensationTotal	295746	usd
	worx	Share Based Compensation Total ShareBasedCompensationTotal	645549	usd
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	3325735	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	3611004	shares
CY2023Q2	worx	Amounts Due To Officers AmountsDueToOfficers	153838	usd
CY2022Q4	worx	Amounts Due To Officers AmountsDueToOfficers	153838	usd
CY2021Q3	us-gaap	Cash Cash Equivalents And Short Term Investments CashCashEquivalentsAndShortTermInvestments	100000	usd
CY2023Q2	us-gaap	Accounts Payable Interest Bearing Noncurrent AccountsPayableInterestBearingNoncurrent	83811	usd
CY2022Q4	us-gaap	Accounts Payable Interest Bearing Noncurrent AccountsPayableInterestBearingNoncurrent	100000	usd
CY2016Q2	us-gaap	Cash Cash Equivalents And Short Term Investments CashCashEquivalentsAndShortTermInvestments	160085	usd
CY2023Q2	us-gaap	Cash Cash Equivalents And Short Term Investments CashCashEquivalentsAndShortTermInvestments	160085	usd
CY2023Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross		usd
CY2023Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent		usd
CY2022Q2	us-gaap	Interest Expense InterestExpense		usd
	us-gaap	Interest Expense InterestExpense		usd
CY2023Q2	us-gaap	Gain Loss On Sales Of Consumer Loans GainLossOnSalesOfConsumerLoans		usd
CY2022Q2	us-gaap	Gain Loss On Sales Of Consumer Loans GainLossOnSalesOfConsumerLoans		usd
CY2022Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense		usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2022Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.05
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.10
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	13420527	shares
CY2023Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	13817517	shares
CY2023Q2	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices		usd
CY2023Q2	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised		usd
	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross		usd
	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices		usd
	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised		usd
CY2022Q2	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross		usd
	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross		usd
	worx	Gain Loss On Settlement Of Accounts Payable GainLossOnSettlementOfAccountsPayable		usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts		usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities		usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities		usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock		usd
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable		usd
	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt		usd
	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt		usd
	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt		usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities		usd
	us-gaap	Interest Paid Net InterestPaidNet		usd
	us-gaap	Income Taxes Paid IncomeTaxesPaid		usd
	worx	Commitment Shares Issued In Conjunction With Capital Raise Amount CommitmentSharesIssuedInConjunctionWithCapitalRaiseAmount		usd
	worx	Shares Issued For Equity Financings SharesIssuedForEquityFinancings		usd
	us-gaap	Stock Issued1 StockIssued1		usd
CY2023Q2	us-gaap	Inventory Net InventoryNet		usd
CY2022Q4	us-gaap	Inventory Net InventoryNet		usd
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Entity Central Index Key EntityCentralIndexKey	0001674227

Files In Submission

Name	View Source	Status
0001213900-23-066853-index-headers.html	Edgar Link	pending
0001213900-23-066853-index.html	Edgar Link	pending
0001213900-23-066853.txt	Edgar Link	pending
0001213900-23-066853-xbrl.zip	Edgar Link	pending
f10q0623ex31-1_scworx.htm	Edgar Link	pending
f10q0623ex31-2_scworx.htm	Edgar Link	pending
f10q0623ex32-1_scworx.htm	Edgar Link	pending
f10q0623ex32-2_scworx.htm	Edgar Link	pending
f10q0623_scworx.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
f10q0623_scworx_htm.xml	Edgar Link	completed
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
worx-20230630.xsd	Edgar Link	pending
worx-20230630_cal.xml	Edgar Link	unprocessable
worx-20230630_def.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
worx-20230630_lab.xml	Edgar Link	unprocessable
worx-20230630_pre.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$WORX
SCWorx Corp. Stock $worx

2023 Q3 Form 10-Q Financial Statement

#000121390023066853 Filed on August 14, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$WORX SCWorx Corp. Stock $worx

2023 Q3 Form 10-Q Financial Statement

#000121390023066853 Filed on August 14, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$WORX
SCWorx Corp. Stock $worx